FlyBase curator comment: this entry represents a transgenic construct where the particular construct used cannot be determined.
Expression of ApplScer\UAS.cUa driven by Scer\GAL4elav.PU causes accumulation of synaptic vesicles in axons (significant increase in Syt1 aggregates compared to controls) at the neuromuscular junction of third instar larvae.
ApplUAS.cUa, Scer\GAL4elav.PU has synaptic vesicle | third instar larval stage phenotype, enhanceable by sraJF02557, Scer\GAL4elav.PU
ApplUAS.cUa, Scer\GAL4elav.PU has embryonic/larval neuromuscular junction | third instar larval stage phenotype, enhanceable by sraJF02557, Scer\GAL4elav.PU
ApplUAS.cUa, Scer\GAL4elav.PU has axon | third instar larval stage phenotype, enhanceable by sraJF02557, Scer\GAL4elav.PU
ApplUAS.cUa, Scer\GAL4elav.PU has synaptic vesicle | third instar larval stage phenotype, suppressible by sraUAS.Tag:HA, Scer\GAL4elav.PU
ApplUAS.cUa, Scer\GAL4elav.PU has embryonic/larval neuromuscular junction | third instar larval stage phenotype, suppressible by sraUAS.Tag:HA, Scer\GAL4elav.PU
ApplUAS.cUa, Scer\GAL4elav.PU has axon | third instar larval stage phenotype, suppressible by sraUAS.Tag:HA, Scer\GAL4elav.PU
Co-expression of sraJF02557 significantly enhances (and sraScer\UAS.T:Ivir\HA1 significantly suppresses) aggregate formation in axons at the neuromuscular junction of Scer\GAL4elav.PU>ApplScer\UAS.cUa larvae.